486 related articles for article (PubMed ID: 22922411)
1. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.
Van Hoecke A; Schoonaert L; Lemmens R; Timmers M; Staats KA; Laird AS; Peeters E; Philips T; Goris A; Dubois B; Andersen PM; Al-Chalabi A; Thijs V; Turnley AM; van Vught PW; Veldink JH; Hardiman O; Van Den Bosch L; Gonzalez-Perez P; Van Damme P; Brown RH; van den Berg LH; Robberecht W
Nat Med; 2012 Sep; 18(9):1418-22. PubMed ID: 22922411
[TBL] [Abstract][Full Text] [Related]
2. Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis.
Rué L; Timmers M; Lenaerts A; Smolders S; Poppe L; de Boer A; Van Den Bosch L; Van Damme P; Robberecht W; Lemmens R
Sci Rep; 2019 Oct; 9(1):14112. PubMed ID: 31575928
[TBL] [Abstract][Full Text] [Related]
3. Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1
Zhao J; Cooper LT; Boyd AW; Bartlett PF
Sci Rep; 2018 Jul; 8(1):11393. PubMed ID: 30061574
[TBL] [Abstract][Full Text] [Related]
4. Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
Rué L; Oeckl P; Timmers M; Lenaerts A; van der Vos J; Smolders S; Poppe L; de Boer A; Van Den Bosch L; Van Damme P; Weishaupt JH; Ludolph AC; Otto M; Robberecht W; Lemmens R
Acta Neuropathol Commun; 2019 Jul; 7(1):114. PubMed ID: 31300041
[TBL] [Abstract][Full Text] [Related]
5. Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis.
Ling KK; Jackson M; Alkam D; Liu D; Allaire N; Sun C; Kiaei M; McCampbell A; Rigo F
Neurobiol Dis; 2018 Jun; 114():174-183. PubMed ID: 29518482
[TBL] [Abstract][Full Text] [Related]
6. Inducible EphA4 knockout causes motor deficits in young mice and is not protective in the SOD1
Dominguez SL; Earr T; Dourado M; Ngu H; Meilandt WJ; Hanson JE
Sci Rep; 2020 Sep; 10(1):15713. PubMed ID: 32973290
[TBL] [Abstract][Full Text] [Related]
7. The identification of a novel isoform of EphA4 and ITS expression in SOD1
Zhao J; Boyd AW; Bartlett PF
Neuroscience; 2017 Apr; 347():11-21. PubMed ID: 28153688
[TBL] [Abstract][Full Text] [Related]
8. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular effects of G93A-SOD1 expression in zebrafish.
Sakowski SA; Lunn JS; Busta AS; Oh SS; Zamora-Berridi G; Palmer M; Rosenberg AA; Philip SG; Dowling JJ; Feldman EL
Mol Neurodegener; 2012 Aug; 7():44. PubMed ID: 22938571
[TBL] [Abstract][Full Text] [Related]
10. Potent and Selective EphA4 Agonists for the Treatment of ALS.
Wu B; De SK; Kulinich A; Salem AF; Koeppen J; Wang R; Barile E; Wang S; Zhang D; Ethell I; Pellecchia M
Cell Chem Biol; 2017 Mar; 24(3):293-305. PubMed ID: 28196613
[TBL] [Abstract][Full Text] [Related]
11. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
[TBL] [Abstract][Full Text] [Related]
12. Rodent Models of Amyotrophic Lateral Sclerosis.
Philips T; Rothstein JD
Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
[TBL] [Abstract][Full Text] [Related]
13. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
14. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.
Dutta K; Thammisetty SS; Boutej H; Bareil C; Julien JP
J Neurosci; 2020 Jun; 40(26):5137-5154. PubMed ID: 32457070
[TBL] [Abstract][Full Text] [Related]
15. Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy.
Poppe L; Smolders S; Rué L; Timmers M; Lenaerts A; Storm A; Schoonaert L; de Boer A; Van Damme P; Van Den Bosch L; Robberecht W; Lemmens R
Front Neurosci; 2019; 13():1233. PubMed ID: 31803009
[TBL] [Abstract][Full Text] [Related]
16. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
[TBL] [Abstract][Full Text] [Related]
17. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
18. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
19. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]